NYSE · Education & Training Services · USD
Covista Inc. (CVSA) Stock Analysis
Covista Inc. (CVSA) is a Education & Training Services stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
CVSA Key Statistics
As of Oct 21, 2026Trading
- Open
- $127.38
- Previous Close
- $127.64
- Day's Range
- 125.92–127.95
- 52-Week Range
- 86.97–156.26
- Volume
- 231.65K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.65
Valuation
- Market Cap
- $4.30B
- P/E Ratio
- 16.95
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 12.69
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.94
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 2.20
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 7.49
Financials (FY)
- Revenue (FY)
- $1.79B+12.85%
- Net Income (FY)
- $237.07M+73.32%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 12.87%
- Shares Outstanding
- 33.86M
- 1-Year Return
- −17.09%
Dividend and dates
- Earnings Date
- October 29, 2026
- Avg Volume
- 336.41K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, CVSA closed at $126.92, −17.09% over 1 year.
Covista Inc. (CVSA) has a market capitalization of $4.30B.
In fiscal 2025, CVSA reported revenue of $1.79B.
CVSA Stock Return by Calendar Year
Covista Inc. (CVSA) 10-year return: what $10,000 became
- 1 year
- $10,000 $8,291
- −17.09%
- 5 years
- $10,000 $34,555
- +245.55%
- 10 years
- $10,000 $56,353
- +463.53%
If you had invested $10,000 in Covista Inc. (CVSA) 10 years ago, at the close on October 21, 2016, it would have been worth $56,353 at the close on October 21, 2026: +463.53% in total, +18.88% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +22.66% |
| 2025 | +13.89% |
| 2024 | +54.11% |
| 2023 | +66.06% |
| 2022 | +20.09% |
| 2021 | −12.93% |
| 2020 | −2.92% |
| 2019 | −26.10% |
| 2018 | +12.53% |
| 2017 | +34.78% |
| 2016 (partial year) | +37.02% |
As of October 21, 2026.
CVSA Revenue and Earnings by Fiscal Year
FY ends June| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $1.79B | $237.07M | 13.3% |
| 2024 | $1.58B | $136.78M | 8.6% |
| 2023 | $1.45B | $93.36M | 6.4% |
| 2022 | $1.38B | $310.99M | 22.5% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $1.79B | $1.02B | $344.86M | $237.07M | 13.3% |
| 2024 | $1.58B | $886.10M | $253.14M | $136.78M | 8.6% |
| 2023 | $1.45B | $802.34M | $216.33M | $93.36M | 6.4% |
| 2022 | $1.38B | $722.07M | $155.57M | $310.99M | 22.5% |
Annual figures as reported, in the company's reporting currency. As of June 30, 2025.
CVSA Valuation vs Education & Training Services Median
Median of 44 stocks| Metric | CVSA | Education & Training Services median | vs median |
|---|---|---|---|
| P/E | 16.95 | 16.95 | 0% above |
| P/S ratio | 2.20 | 0.84 | 161% above |
| Profit margin | 12.87% | 3.14% | 9.7 pts above |
Medians across 44 Education & Training Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Students at Covista Medical Schools Match or Exceed U.S. MD Peers on USMLE Step 1 First-Time Pass Rates Across MCAT Ranges
YahooFull Transcript: Covista Q4 2026 Earnings Call
BenzingaCovista (NYSE:CVSA): A GARP Case Backed by Reasonable Growth and Valuation
ChartMill3 Reasons to Avoid CVSA and 1 Stock to Buy Instead
YahooBMO Capital Maintains Outperform on Covista, Lowers Price Target to $145
BenzingaCovista Announces First Quarter Fiscal Year 2027 Conference Call
Yahoo
All 20 articles ↓Show fewer ↑
The Health Collaborative receives $150,000 investment from Covista, the parent company for Chamberlain University, to Expand Healthcare Career Exploration Opportunities for Greater Cincinnati Students
YahooCovista to Participate in September Investor Conferences
YahooCovista (CVSA) Could Be 20% Undervalued As Workforce Shortages Support Its Growth Story
YahooTruist Securities downgrades Covista to Hold from Buy
FintelTruist Securities Downgrades Covista to Hold, Maintains Price Target to $140
BenzingaCovista: Strong Secular Growth And Operating Leverage
SeekingAlphaCovista Q4 Earnings & Revenues Top Estimates, Enrollments Up Y/Y
YahooCovista Inc (CVSA) (Q4 2026) Earnings Call Highlights: Record Enrollment and Strong Cash Flow ...
YahooCovista (NYSE:CVSA) Beats Q4 EPS Estimates and Guides Fiscal 2027
ChartMillCovista (CVSA) Q4 Earnings and Revenues Top Estimates
YahooCovista Inc. (CVSA) Q4 2026 Earnings Call Transcript
SeekingAlphaCovista Inc. 2026 Q4 - Results - Earnings Call Presentation
SeekingAlphaCovista’s (NYSE:CVSA) Q2 CY2026 Sales Top Estimates
YahooCovista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; Initiates Fiscal Year 2027 Guidance
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Education & Training Services Stocks
New Oriental Education & Technology Group Inc.
$9.22B
TALTAL Education Group
$5.85B
LAURLaureate Education, Inc.
$5.28B
LOPEGrand Canyon Education, Inc.
$4.16B
XXITwenty One Capital, Inc.
$3.84B
LRNStride, Inc.
$3.17B
Popular Consumer Defensive Stocks
Walmart Inc.
$937.46B
COSTCostco Wholesale Corporation
$442.38B
KOThe Coca-Cola Company
$398.76B
PGThe Procter & Gamble Company
$364.29B
PMPhilip Morris International Inc.
$307.76B










